成人精品一卡二卡三卡_久久99国产精品无码AV_蜜臀久久99精品久久久久久_亚洲一日欧美日韩中文字幕,精品国产一区二区三区免费_亚洲国产精品综合久久20_中文字幕一区二区三区日韩精品_国产精品对白交换视频_国产午夜福利精品一区二区三区_国产精品亚洲一区二区三区久久_久久99精品国产99久久6男男_国产精品亚洲综合久久_国精产品一区一区三区有限在线,国产精品VIDEOSSEX久久发布-国产伦精品一区二区三区妓女-99久久综合精品五月天-国产精品99久久免费观看-国产久热精品无码激情

供貨周期	現(xiàn)貨	規(guī)格	T-25 Flask
貨號	CBP73193	應用領域	生物產(chǎn)業(yè)
主要用途	僅限科研使用

CBP73193
I. Introduction
Cell Line Name：	TFG-NTRK1/BaF3
Host Cell:	Ba/F3
Stability:	16 passages (in-house test, that not means the cell line will be instable beyond the passages we tested.)
Application:	Anti-proliferation assay and PD assay
Freeze Medium:	90% FBS+10% DMSO
Complete Culture Medium:	RPMI-1640+10% FBS+1 ug/ml puromycin
Mycoplasma Status:	Negative

II.Background
NTRK1 rearrangements involve the kinase domain of the NTRK1 gene which includes 17 exons located on chromosome 1q21-22 (Alberti et al. 2003). The frequency of NTRK1 fusions in patients with adenocarcinoma histology is 3.3% of cases (3 out of 91 patients; Vaishnavi et al. 2013). a In preclinical studies, cell lines expressing MPRIP-NTRK1 or CD74-NTRK1 were inhibited by ARRY-470, a TRKA/B/C inhibitor (Vaishnavi et al. 2013). b In preclinical studies, cell lines expressing MPRIP-NTRK1 or CD74-NTRK1 were inhibited by lestaurtinib, a FLT3/TRKA inhibitor (Vaishnavi et al. 2013). c A patient with non-small cell lung cancer harboring an MPRIP-NTRK1 fusion mutation was treated with crizotinib, which has activity against TRKA in addition to ALK, MET and ROS1 (Vaishnavi et al. 2013). The patient demonstrated a small radiographic decrease in tumor size but experienced disease progression after three months (Vaishnavi et al. 2013)

III. Representative Data
1. WB of TFG-NTRK1/BaF3 expression

2. Anti-proliferation assay

Figure 2. Anti-proliferation assay of two reference compounds on the TFG-NTRK1/BaF3 Stable Cell Line